Phase 2 N=109 Moderate Alcohol Intake Among Patients With Type 2 Diabetes
Type 2 Diabetes
Primary: Glucose — -21.55; 1.92 mg/dL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=16 Effects of Alcoholic Beverages in Pro-inflammatory and Antioxidant Profile After an Oral Fat Diet
Alcohol Consumption
Primary: Change From Baseline in Concentrations of Antioxidant Profile After Red Wine Intake — 22.3; 12.7 percentage of change in TAC — p=0.05
Phase 2 N=64 Examining Alcohol Consumption, Perceptions, and User Experience of Alcohol Moderation Strategies
Alcohol Abuse · Alcohol Use Disorder · Alcohol Abuse, Episodic
Primary: The Young Adult Alcohol Consequences Questionnaire — -4.48; -4.63 outcome score minus baseline score
N/A N=37 Biobehavioral Pathways Underlying Alcohol Use and Health
Alcohol Use Disorder · Liver Diseases
Primary: Percentage of Screen Eligible Who Enroll — 28; 5 Participants
N/A N=99 Alcohol Intervention for First Year College Students
Underage Alcohol Use
Primary: Acceptability-Number of Participants Who Found the Study Overall Favorable — 38; 0 Participants
N/A N=122 PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)
Hazardous Alcohol Use
Primary: Intervention Feasibility: Intervention Uptake — 122 Participants
N/A N=134 Records for Alcohol Care Enhancement
Alcohol Use Disorder (AUD)
Primary: Percent of New Alcohol Use Disorder (AUD) Diagnosis Episodes That Meet Criteria for AUD Treatment Engagement Among Patients With a New AUD Diagnosis Who Are Empaneled to…
N/A N=12 The Effects of Alcohol Consumption on Central Adiposity
Alcohol Drinking · Weight Loss · Adiposity
Primary: Change in Central (Abdominal) Adiposity — -0.250; -0.071 kg — p=<0.231
N/A N=360 Alcohol Metabolism and Disease Risk in Asians
Healthy
Primary: Peak Number of Alcohol Drinks Consumed in a Day — 3.7; 4.2; 3.4; 3.0 drinks — p=.81
N/A N=44 Satiety and Alcohol Challenge
Alcohol Drinking
Primary: Change in Alcohol Specific Satiety Score — -0.51; 4.85 score on a scale
Phase 2 N=60 Prevention of Alcohol Intolerance
Alcohol Sensitivity
Primary: Mean Area of Skin Erythema (Skin Redness) — 3.968; 1.739 centimeters^2
N/A N=180 Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
Alcoholism
Primary: Number of Drinks Felt Consumed at Baseline — 0; 0; 0; 0 drinks felt consumed
N/A N=20 Alcohol and Breast Cancer (ABC) Trial
ER+ Breast Cancer · Breast Cancer · Aromatase Inhibitors
Primary: Blood Levels of Total Estradiol Concentration — -0.50; -0.39 Log scale, pg/mL
Phase 2 N=62 Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
Alcohol Abuse · Impulsive Behavior
Primary: Number of Drinks Consumed in a Laboratory Bar Session — 2.69; 2.96; 2.73; 2.39 drinks
Phase 2 N=44 Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
Alcohol Reactivity
Primary: Cognitive Function as Measured by Omissions on the CPT — 1.78; 1.28; 4.76; 0.98 Number of Omissions
Phase 2 N=46 Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
Alcohol Drinking
Primary: Alcohol Consumption — 92.0; 77.3 mg/%
N/A N=303 The Impact of Alcohol Consumption on Tuberculosis Treatment Outcomes
Tuberculosis · Alcohol Consumption · Treatment Adverse Effect
Primary: Time to Culture Conversion — 5.6; 5.4; 5.5 weeks
N/A N=1,053 Evaluations of Alcohol Warning Labels
Oral Cancer · Esophageal Cancer · Larynx Cancer
Primary: Dwell Time — 8.75; 8.47 seconds
N/A N=352 Brief Alcohol E-Interventions Study
Alcohol Drinking in College
Primary: Mean Drinks Per Day — .93; 1.15; .86; 1.38 Drinks per day — p=<.05
Phase 2 N=13 Effect of Endotoxin on Alcohol Consumption
Alcohol Use Disorder
Primary: Alcohol Consumption — 37.57; 50.08 Milliliters
Phase 4 N=302 Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)
Tuberculosis · HIV/AIDS · Alcohol Abuse
Primary: Cumulative Incidence of Participants Experiencing a Grade 3/4 Hepatotoxicity — 8.3 percent
Phase 1 N=34 Mavoglurant in Alcohol Drinking
Alcohol Drinking
Primary: Abnormal Labs and Adverse Events — 9; 8; 0; 0 Participants
Phase 1 N=537 Alcohol Health Education Among College Drinkers
College Student Drinking
Primary: Alcohol Consumption — 16.929; 17.988; 18.039 drinks
Phase 2 N=120 Addressing Heavy Alcohol Use Consumption With Kudzu
Alcohol Use Disorder · Sexually Transmitted Diseases
Primary: Number of Binge Drinking Days — 2.15; 2.15; 1.94; 2.21 number of days
N/A N=444 Brief Online Interventions for Alcohol Use
Alcohol Use Disorder
Primary: Alcohol Use — 19.4; 16.3; 15.3; 19.1 percentage heavy drinking days
Phase 2 N=111 Family History Study of Alcohol Consumption Using Memantine
Alcohol Drinking
Primary: Number of Drinks Consumed on Day 7 — 5.84; 5.61; 6.21 standard drinks
N/A N=285,304 Sustaining Patient-centered Alcohol-related Care
Alcohol, Drinking · Alcohol Use Disorder
Primary: Brief Alcohol Counseling Rate — 57; 11 participants per 10,000 with visits — p=<.001
Phase 2 N=60 Do Treatments for Smoking Cessation Affect Alcohol Drinking?
Alcohol Drinking
Primary: Number of Drinks Consumed — 2.1; 2.05; 1.5; 1.7 number of drinks
Phase 2 N=50 Saracatinib and Alcohol Drinking
Alcohol Drinking
Primary: Change in the Number of Drinks Consumed From Baseline to Day 8 (Minus Baseline) — -1.85; -2.33 drinks
N/A N=38 Alcohol and Neural Cardiovascular Control in Binge Drinkers
Binge Drinking
Primary: Sympathetic Nerve Activity Burst Frequency — 18; 20 Burst/Min — p=0.283